Ruf J, Ferrand M, Durand-Gorde J M, Carayon P
U 38 INSERM, Faculté de Médecine, Marseille, France.
Autoimmunity. 1992;11(3):179-88. doi: 10.3109/08916939209035153.
The presence of autoantibodies (aAbs) to thyroglobulin (TG) and thyroperoxidase (TPO) in most of the patients with autoimmune thyroid disease is now well documented. Studies of these aAbs suggested that some, termed TGPO aAbs, could interact with both TG and TPO. This hypothesis was investigated using IgG fraction from a pool of 25 patients' sera with high TG and TPO aAb titres. Immunopurification of TG, TPO and TGPO aAbs was carried out by sequential affinity chromatography using a large quantity of highly purified human TG and TPO. TGPO aAbs, obtained absorption-elution of affinity purified TG aAbs onto a TPO column, were found to represent about 20% of the TG reactive aAbs and 0.23% of the total amount of IgG. Purified TGPO aAbs were characterized and compared to specific TG and TPO aAbs. In contrast to TG and TPO aAbs which recognized only their target antigen, TGPO aAbs showed high affinity interactions with both TG and TPO. As compared to TG aAbs, TGPO aAbs displayed similar affinity for native TG and higher affinity for denatured TG. Compared to TPO aAbs, TGPO aAbs showed lower affinity for both native and denatured TPO. TGPO aAbs also differed from specific TG and TPO aAbs with regard to IgG subclass distribution and antigen fine specificities as determined by monoclonal antibody assisted mapping of TG and TPO surface epitopes. Taken together, these data indicate that TGPO aAbs are effectively present in the serum of patients with autoimmune thyroid disease. TGPO aAbs may be considered as a subpopulation of TG aAbs with the unique property to cross-react with TPO. The existence of aAbs cross-reacting with these functionally and antigenically related thyroid molecules could lead to a re-examination of the emergence of thyroid autoimmunity.
目前已有充分证据表明,大多数自身免疫性甲状腺疾病患者体内存在针对甲状腺球蛋白(TG)和甲状腺过氧化物酶(TPO)的自身抗体(aAbs)。对这些自身抗体的研究表明,其中一些被称为TGPO自身抗体的物质能够与TG和TPO两者相互作用。本研究使用来自25例TG和TPO自身抗体滴度较高患者血清池的IgG组分对这一假设进行了验证。通过使用大量高度纯化的人TG和TPO进行连续亲和层析,对TG、TPO和TGPO自身抗体进行了免疫纯化。通过将亲和纯化的TG自身抗体吸附洗脱至TPO柱上获得的TGPO自身抗体,约占TG反应性自身抗体的20%,占IgG总量的0.23%。对纯化后的TGPO自身抗体进行了特性鉴定,并与特异性TG和TPO自身抗体进行了比较。与仅识别其靶抗原的TG和TPO自身抗体不同,TGPO自身抗体与TG和TPO均表现出高亲和力相互作用。与TG自身抗体相比,TGPO自身抗体对天然TG的亲和力相似,但对变性TG的亲和力更高。与TPO自身抗体相比,TGPO自身抗体对天然和变性TPO的亲和力均较低。通过单克隆抗体辅助绘制TG和TPO表面表位来确定,TGPO自身抗体在IgG亚类分布和抗原精细特异性方面也与特异性TG和TPO自身抗体不同。综上所述,这些数据表明TGPO自身抗体确实存在于自身免疫性甲状腺疾病患者的血清中。TGPO自身抗体可被视为TG自身抗体的一个亚群,具有与TPO交叉反应的独特特性。与这些功能和抗原相关的甲状腺分子发生交叉反应的自身抗体的存在,可能会促使人们重新审视甲状腺自身免疫的发生机制。